Volasertib (compound code BI 6727)
Volasertib* and Polo-like kinase (Plk) inhibition
PLK1 inhibitor
PLK1 and Polo arrest
PLK1 and cell division
Cell-Cycle Control
PLK1 and cell cycle kinases
Source for healthcare professionals: www.inoncology.com* BIBF 1120, BIBW 2992 and BI 6727 are investigational compounds. Their safety and efficacy have not yet been fully established.